Table 1.
Pathway method | Across 500 null sets | Across 500 nonspurious gene sets | ||
---|---|---|---|---|
Nominal α = 0.05 | Nominal α = 0.005 | Nominal α = 0.05 | Nominal α = 0.005 | |
No gene-level aggregation | ||||
WS | 0.492 | 0.190 | 0.043 | 0.004 |
CMC | 0.232 | 0.054 | 0.037 | 0.003 |
Gene-level aggregation | ||||
WS-GSEA | 0.048 | 0.004 | 0.001 | 0.000 |
WS-KS | 0.040 | 0.003 | 0.000 | 0.000 |
WS-Fisher | 0.429 | 0.244 | 0.010 | 0.004 |
CMC-GSEA | 0.063 | 0.007 | 0.002 | 0.000 |
CMC-KS | 0.044 | 0.004 | 0.004 | 0.000 |
CMC-Fisher | 0.484 | 0.235 | 0.048 | 0.006 |
WS, weighted sum; CMC, combined multivariate collapsing; GSEA, gene set enrichment analysis; KS, Kolmogorov-Smirnov test; Fisher, Fisher’s combined probability test.